The firms have developed a cannabis sequencing panel, called myBaits MGC Cannabis Panel, which they will be offering for sequencing service work.
As labs implement TMB workflows in-house, studies are showing that its is possible to validate assays with cutoff points remaining stable across complex clinical cohorts and in different drug contexts.
The funding will support the use of a new in situ RNA sequencing technology, STARmap, to build functional maps of the developing brain and brain tumors.
Columbia and Qiagen filed a suit against Illumina in federal court today, alleging infringement of two patents that were issued today.
The victory for the sequencing giant is just the latest in a string of favorable decisions before the US Patent Trial and Appeals Board.
CFSRE recently validated Verogen's NGS-based forensics platform and will develop implementation and training materials for law enforcement.
Personalis will analyze samples from the study, evaluating the pharma company's novel therapy INVAC-1 either as a monotherapy or in combination with the TKI ibrutinib.
The firms plan to use Thermo Fisher's Oncomine Dx Target test to identify cancer patients with RET alterations who might benefit from Lilly's LOXO-292.
The San Diego-based firm has developed a new extracellular RNA sequencing method that it believes could be used for cancer diagnostics.
The health technology firm is proposing a new software solution that would standardize coding in genetic testing, but a more predictable system would also narrow variability in test pricing.
The team analyzed multigene panel test data from Ambry Genetics for 165,000 individuals, focusing on hereditary cancer risk related to 32 genes in six cancer types.
By sequencing an Indus Valley Civilization representative and related individuals, investigators learned more about the South Asian ancestry, farming history, and languages.
The French metagenomic sequencing firm received funding from both historical and new investors, including debt financing from Norgine Ventures.
The San Francisco-based microbial genomics firm will sell off its product lines, testing labs, IP, and data within the next three months.
In response to BD's patent suit, 10x alleged BD's single-cell products infringe its own patents. 10x also asked the judge to dismiss BD's lawsuit.
The combined firm will be based in Gaithersburg, Maryland and will focus on infectious disease diagnostics and antimicrobial resistance prediction services.
Based on runs of homozygosity, researchers estimated that roughly one in every 3,650 participants had parents who were first- or second-degree relatives.
Investigators plan to profile clonal hematopoiesis in a broad range of patients to get a clearer look at its interactions with aging and disease.
The genetic testing firm has entered into an equity distribution agreement with Piper Jaffray to offer up to $30 million in stocks, with an initial offering of $22.5 million.
The company believes that Xdrop will find adopters in academia and clinical research, although diagnostics is on its radar.
NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.
According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.
A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.
In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.